The Effect of Cupping on Spasticity and Function of the Lower Extremity During Rehabilitation After Stroke

December 10, 2024 updated by: Scott Getsoian
Physical therapists use dry static cupping for the treatment of many conditions, including spasticity for patients post-stroke. While research better describes the effects of dry static cupping for patients with orthopedic conditions, information is lacking on central conditions, such as stroke and resulting spasticity.

Study Overview

Detailed Description

Cupping is an ancient alternative medicine. A common form of cupping, called dry static cupping, involves creating negative pressure inside a therapeutic cup. The cup is then placed on the skin, creating a light suction effect. In Eastern Medicine, cupping has been used to treat a variety of diseases. More recently, in Western society, cupping has been used after injury, and among other effects, has been found to improve blood volume and tissue oxygenation to an area. These effects have originally been thought to be peripheral in nature, occurring at the cupping site, hence, why cupping has been used for treatment for conditions like carpal tunnel syndrome, spinal pain, knee osteoarthritis, and other musculoskeletal conditions.

However, a recent systematic review found cupping to be beneficial for rehabilitation after stroke. These conclusions raise the question of a possible mechanism for cupping to improve impairments related to the central nervous system, such as spasticity after stroke. However, many of the studies to date have serious methodological flaws that limit the direct causation of cupping to the reduction of spasticity. As well, the majority of studies only involve the upper extremity. No study has yet looked at the therapeutic effects of dry static cupping on lower extremity spasticity reduction after stroke.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 30-80
  • Acute stroke (within 6 months of stroke), with spasticity & hemiparesis of LE
  • Referred by doctor for rehabilitation for a stroke-related condition
  • Attending Ascension Rehabilitation of Joliet for rehabilitation
  • Able to read or verbally understand English or Spanish

Exclusion Criteria:

  • Absent sensation of the areas to be cupped
  • Significant cognitive impairment
  • Pregnancy
  • Prescription anticoagulant medications
  • Blood clotting disorder
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Open wounds within the cupping area
  • Current DVT
  • Hematoma over the cupping area
  • Fracture over the cupping area
  • Active cancer within the cupping area
  • Current use of Baclofen
  • Current use of Botox
  • Current use of an anti-spasticity medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Cupping group
This group (arm) will receive the dry static cupping intervention, along with the standard physical therapy treatment.
A myofascial decompression cupping set with a precision pressure pump will be used to perform dry static cupping to the adductor and hamstring muscle groups of the affected limb, using a negative pressure of 300mmHg for eight minutes each.

Treatment will consist of typical physical therapy interventions performed for patients with spasticity of the lower extremity after stroke. These may include, but not be limited to:

  • Balance exercise
  • Therapeutic exercise
  • Neuromuscular/muscular coordination exercise
  • Manual (hands on) therapy
  • Gait training

The treating physical therapist is left with the autonomy of the standard physical therapy treatment (within the above stated groups of interventions) because patients with the diagnosis of stroke do not all present with the same type or level of impairment. Furthermore co-morbidities (e.g., hypertension) and/or functional level (wheelchair bound vs. independent ambulator) may necessitate different treatment strategies. Therefore, while the general categories of treatment will remain the same across all study patients, it is expected that the treating physical therapist provides patient-specific interventions.

Sham Comparator: Placebo cupping group
This group (arm) will receive a placebo-form of cupping (low, and non-therapeutic pressure amount in the cups), along with the standard physical therapy treatment.
The same protocol will be used as stated for the Dry static cupping intervention, with the only difference being that the cup will be pumped to 50mmHg instead of 300mmHg.

Treatment will consist of typical physical therapy interventions performed for patients with spasticity of the lower extremity after stroke. These may include, but not be limited to:

  • Balance exercise
  • Therapeutic exercise
  • Neuromuscular/muscular coordination exercise
  • Manual (hands on) therapy
  • Gait training

The treating physical therapist is left with the autonomy of the standard physical therapy treatment (within the above stated groups of interventions) because patients with the diagnosis of stroke do not all present with the same type or level of impairment. Furthermore co-morbidities (e.g., hypertension) and/or functional level (wheelchair bound vs. independent ambulator) may necessitate different treatment strategies. Therefore, while the general categories of treatment will remain the same across all study patients, it is expected that the treating physical therapist provides patient-specific interventions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Ashworth Scale
Time Frame: At enrollment and then at 1, 2, and 3 months of treatment.

The Modified Ashworth Scale measures spasticity on a 0-4 ordinal scale, with higher scores indicating greater spasticity. The grade is determined by passively moving a joint/muscle through a high velocity unidirectional quick stretch. For this study, spasticity will be assessed for the hip adductors and hamstrings of the affected side.

Equipment:

Mat Table

Administration:

Patient is positioned in supine on a mat table.

For Hip Adduction: Physical therapist passively moves the affected lower extremity into hip abduction quickly keeping the knee in extension.

For Hamstrings: Physical therapist passively moves the hip to 90 degrees of flexion and allows the knee to bend into knee flexion. Then, the therapist passively moves the affected knee into extension quickly.

At enrollment and then at 1, 2, and 3 months of treatment.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six-Minute Walk Test (6MWT)
Time Frame: At enrollment and then at 1, 2, and 3 months of treatment.

The Six-minute Walk Test is a measure of aerobic capacity and gait. It is measured in feet on a ratio scale.

Administration:

The patient is instructed to walk down an unobstructed path for six minutes, while the physical therapist walks behind them with a stopwatch and rolling tape measure to monitor the time and steps of the patient during the test. The distance (in feet) that the patient walked, after six minutes, is used as the score for the test.

To note: blood pressure will be taken before and after the test.

At enrollment and then at 1, 2, and 3 months of treatment.
Timed Up and Go (TUG) Test
Time Frame: At enrollment and then at 1, 2, and 3 months of treatment.

The TUG assesses mobility, ability, and fall risk in older adults. It is measured in seconds, on a ratio scale.

Equipment:

  • Chair with armrests
  • Stopwatch
  • Marker to designate 10' turn around point

Administration:

  • The patient sits in the chair
  • On the command "ready and go" the patient gets up from the chair, walks 10 feet at a comfortable and safe pace, turns, walks back to the chair and sits down.
  • Timing begins at the instruction "go" and stops when the patient is seated
  • The patient must use the same assistive device for each assessment time, but is able to complete the test with multiple devices or no device.
  • The physical therapist will demonstrate the activity to the patient.
At enrollment and then at 1, 2, and 3 months of treatment.
Berg Balance Scale (BBS)
Time Frame: At enrollment and then at 1, 2, and 3 months of treatment.

The Berg Balance Scale is a 14-item test that measures static balance and fall risk in adults. Each item is scored on a 0-4 ordinal scale. At conclusion of the 14 items, the score is tallied.

Equipment: Chair with arms, Chair without arms, Mat, Stopwatch, Yardstick, Slipper/sandal, 7 ¾" step, Blind fold, Tape.

Items (14):

  1. sitting to standing
  2. standing unsupported
  3. sitting unsupported with feet on floor
  4. standing to sitting
  5. transfers
  6. standing unsupported with eyes closed
  7. standing unsupported with feet together
  8. reaching forward with outstretched arm
  9. pick up object from floor
  10. turn to look behind over each shoulder
  11. turning 360 degrees
  12. dynamic weight shifting while standing unsupported
  13. standing unsupported one foot in front
  14. standing on one leg
At enrollment and then at 1, 2, and 3 months of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

October 21, 2024

First Submitted That Met QC Criteria

October 21, 2024

First Posted (Actual)

October 22, 2024

Study Record Updates

Last Update Posted (Estimated)

December 13, 2024

Last Update Submitted That Met QC Criteria

December 10, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke Gait Rehabilitation

Clinical Trials on Dry Static Cupping

Subscribe